TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

YILING

NeurologyCardiovascularInfectious Disease
Generics

YILING is a generic drug manufacturer focused on Neurology, Cardiovascular, Infectious Disease.

1996
Since
13
Drugs
-
Trials
185
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
CELECOXIB 2026-02-12
Labeling
PREGABALIN 2026-02-03
Labeling
PREGABALIN 2026-02-02
Labeling
PREGABALIN 2026-02-02
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 33%
2 drugs Phase 1: 3
Cardiovascular 27%
2 drugs
Infectious Disease 13%
1 drugs
Dermatology 13%
1 drugs
Metabolic 13%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

B BRAUN specialty
Infectious Disease, Dermatology, Metabolic, Cardiovascular
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Novo Nordisk big-pharma
Metabolic, Cardiovascular, Infectious Disease, Neurology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Dermatology